Urinary endothelin and renal vasoconstriction with cyclosporine or FK506 after liver transplantation. (Q54174772)

25 May 2018

title

Urinary endothelin and renal vasoconstriction with cyclosporine or FK506 after liver transplantation. (English)

1 reference

25 May 2018

1 reference

liver transplantation

1 reference

1 reference

Textor SC

1

1 reference

25 May 2018

Burnett JC Jr

2

1 reference

25 May 2018

Romero JC

3

1 reference

25 May 2018

Canzanello VJ

4

1 reference

25 May 2018

Taler SJ

5

1 reference

25 May 2018

Wiesner R

6

1 reference

25 May 2018

Porayko M

7

1 reference

25 May 2018

Krom R

8

1 reference

25 May 2018

Gores G

9

1 reference

25 May 2018

Hay E

10

1 reference

25 May 2018

language of work or name

English

0 references

publication date

1 May 1995

1 reference

25 May 2018

published in

Kidney International

1 reference

25 May 2018

volume

47

1 reference

25 May 2018

issue

5

1 reference

25 May 2018

page(s)

1426-1433

1 reference

25 May 2018

https://scigraph.springernature.com/pub.10.1038/ki.1995.200

exact match

0 references

cites work

Cyclosporine Nephrotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.200

7 January 2021

Nephrotoxic effects of immunosuppression

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.200

7 January 2021

Systemic and renal hemodynamic differences between FK506 and cyclosporine in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.200

7 January 2021

De novo hypertension after liver transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.200

7 January 2021

Role of endothelin in cyclosporine-induced glomerular dysfunction.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.200

7 January 2021

Cyclosporine-induced synthesis of endothelin by cultured human endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.200

7 January 2021

Endothelin receptor antagonism is protective in in vivo acute cyclosporine toxicity

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.200

7 January 2021

Effect of nifedipine on cyclosporine A-induced nephrotoxicity, urinary endothelin excretion and renal endothelin receptor number

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.200

7 January 2021

Elevation of plasma endothelin associated with systemic hypertension in humans following orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.200

7 January 2021

Cyclosporine-induced elevation in circulating endothelin-1 in patients with solid-organ transplants

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.200

7 January 2021

Daily renal hypoperfusion induced by cyclosporine in patients with renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.200

7 January 2021

Cyclosporin reduces renal prostanoid excretion in type 1 diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.200

7 January 2021

Effects of ciclosporin on plasma renin activity, catecholamines and prostaglandins in patients with idiopathic uveitis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.200

7 January 2021

The first 100 liver transplantations at the Mayo Clinic

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.200

7 January 2021

Renal vascular response to sodium loading in sons of hypertensive parents.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.200

7 January 2021

Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.200

7 January 2021

Measurement of prostaglandins in the cerebrospinal fluid in cat, dog, and man.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.200

7 January 2021

Renal actions of endothelin: linking cellular signaling pathways to kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.200

7 January 2021

Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.200

7 January 2021

Inhibition of endothelium-derived relaxing factor enhances endothelin-mediated vasoconstriction

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.200

7 January 2021

Cyclosporine- and FK506-induced sympathetic activation correlates with calcineurin-mediated inhibition of T-cell signaling.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.200

7 January 2021

Prevention of acute graft rejection by the prostaglandin E1 analogue misoprostol in renal-transplant recipients treated with cyclosporine and prednisone

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.200

7 January 2021

Systemic and renal effects of nifedipine in cyclosporine-associated hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.200

7 January 2021

Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.200

7 January 2021

Cyclosporin in therapeutic doses increases renal allograft vascular resistance.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.200

7 January 2021

Acute cyclosporine renal dysfunction reversed by dopamine infusion in healthy subjects

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.200

7 January 2021

Cyclosporine induces elevated procollagen alpha 1 (I) mRNA levels in the rat renal cortex

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.200

7 January 2021

Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.200

7 January 2021

Growth factor activity of endothelin on vascular smooth muscle

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.200

7 January 2021

Effects of endothelins on collagen turnover in cardiac fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.200

7 January 2021

Identification of two types of specific endothelin receptors in rat mesangial cell

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.200

7 January 2021

Potent vasoconstriction mediated by endothelin ETB receptors in canine coronary arteries.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.200

7 January 2021

Biological actions and pathophysiologic significance of endothelin in the kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.200

7 January 2021

Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.200

7 January 2021

Urinary excretion rate of endothelin-1 in patients with essential hypertension and salt sensitivity

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.200

7 January 2021

Identifiers

DOI

10.1038/KI.1995.200

1 reference

25 May 2018

PubMed ID

7543625

1 reference

25 May 2018